Production (Stage)
GoHealth, Inc.
GOCO
$5.75
-$0.01-0.17%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 834.27M | 798.89M | 686.46M | 700.20M | 737.11M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 834.27M | 798.89M | 686.46M | 700.20M | 737.11M |
Cost of Revenue | 131.87M | 130.61M | 119.46M | 135.77M | 151.51M |
Gross Profit | 702.40M | 668.28M | 567.00M | 564.43M | 585.60M |
SG&A Expenses | 559.93M | 537.50M | 491.95M | 483.74M | 512.68M |
Depreciation & Amortization | 94.06M | 94.06M | 94.06M | 94.06M | 94.06M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 825.39M | 803.21M | 745.99M | 755.93M | 802.56M |
Operating Income | 8.88M | -4.32M | -59.53M | -55.73M | -65.45M |
Income Before Tax | 7.68M | -5.05M | -67.33M | -139.00M | -149.95M |
Income Tax Expenses | 3.44M | 2.27M | 257.00K | 160.00K | 127.00K |
Earnings from Continuing Operations | 4.24 | -7.32 | -67.59 | -139.16 | -150.07 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -2.36M | 4.39M | 37.93M | 78.81M | 86.78M |
Net Income | 1.88M | -2.93M | -29.66M | -60.35M | -63.29M |
EBIT | 8.88M | -4.32M | -59.53M | -55.73M | -65.45M |
EBITDA | 106.90M | 93.47M | 38.48M | 42.13M | 32.48M |
EPS Basic | -0.21 | -0.74 | -3.38 | -6.57 | -7.15 |
Normalized Basic EPS | -4.04 | -4.31 | -4.39 | -0.06 | 0.21 |
EPS Diluted | -1.25 | -1.77 | -3.49 | -6.57 | -7.15 |
Normalized Diluted EPS | -2.88 | -3.15 | -2.96 | -0.06 | 0.21 |
Average Basic Shares Outstanding | 40.58M | 39.92M | 39.35M | 38.76M | 37.91M |
Average Diluted Shares Outstanding | 51.30M | 50.64M | 43.85M | 38.76M | 37.91M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -3.00% | -2.95% | -4.22% |